EUCTR2006-004650-24-DE进行中（未招募）不适用
Omeprazole and reflux disease - improvement of clinical outcome by genotype-adjusted dosing - GERD-Studie
IKP0 个研究点开始时间: 2006年12月13日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Reflux Oesophagitis grade A and B
- •Body Mass Index 20-30
- •Age 20-70 years
- •written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with known sensitivity to omeprazole
- •deficiency of lactase
- •no written informed consent
研究者
相似试验
终止
4 期
Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted DosingGastroesophageal RefluxNCT00537732Matthias Schwab68
已完成
3 期
Treatment of Gastro-esophageal Reflux Disease in Victims of Mustard Gas Exposure with Chronic CoughGastro-oesophageal reflux disease.Gastro-oesophageal reflux diseaseIRCT2012072510398N1Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences60
进行中（未招募）
不适用
Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm.GORD,EUCTR2013-002026-22-NLErasmusMC
已完成
2 期
Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia: A pharmacodynamic and pharmacokinetic studyGastroesofageal reflux diseaseGORD10017943NL-OMON38919Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
不适用
A study to evaluate the benefit of omeprazole in the prevention of bleeding from esophageal ulcer after esophageal varicesPatients with esophageal ulcer (no less than 20 years old)JPRN-UMIN000005749Gifu University30